Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Kit for detecting active pulmonary tuberculosis

A tuberculosis and active technology, applied in the field of kits for detecting active tuberculosis, can solve the problems of no tuberculosis-specific serum miRNAs composition research reports, unreliability, and low specificity, and achieve precise design and high accuracy sex, early warning and early diagnosis

Active Publication Date: 2014-07-23
ZHEJIANG UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to the requirements of disease biomarker research, 1-2 miRNAs are used as disease markers, with low specificity
At the same time, due to the individual differences of different patients, it is extremely unreliable to use only 1-2 miRNAs to judge the disease
However, there is no research report on the composition of tuberculosis-specific serum miRNAs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for detecting active pulmonary tuberculosis
  • Kit for detecting active pulmonary tuberculosis
  • Kit for detecting active pulmonary tuberculosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A diagnostic kit for detecting active pulmonary tuberculosis, the kit has RNA extraction buffer, active pulmonary tuberculosis specific serum miRNA composition: hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 and internal reference reverse transcription primers and PCR primers, fluorescent quantitative RT-PCR reaction solution.

[0032] The reverse transcription primer sequence is:

[0033]hsa-miR-29c:5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTAACCG-3';hsa-miR-22:5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAGTT-3';hsa-miR-320b:5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCCGTT-3';hsa-miR-101:5' -GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTTCAGT-3';

[0034] Internal reference hsa-miR-16: 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCGCCAA-3'.

[0035] The PCR upstream primer sequence is:

[0036] hsa-miR-29c: 5'-GGCGGTAGCACCATTTGAA-3';

[0037] hsa-miR-22: 5'-CGGAAGCTGCCAGTTGAAGA-3';

[0038] hsa-miR-320b: 5'-AAAAGCTGGGTTGAGAGGGCA-3';

[0039...

Embodiment 2

[0047] Example 2 Kit application

[0048] Detect the expression levels of hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 in the serum of patients with active pulmonary tuberculosis, healthy controls, lung cancer patients, pneumonia patients and patients with chronic obstructive pulmonary disease .

[0049] Sample collection: 82 patients with active pulmonary tuberculosis, 108 healthy controls, 30 patients each with lung cancer, pneumonia and chronic obstructive pulmonary disease.

[0050] Collect the total RNA in the serum sample: add 700 μL Qiagen lysate to 200 μL serum sample and mix well, let stand for 5 minutes; add 140 μL chloroform, shake vigorously, let stand for 3 minutes; 12000 rpm, 4 ℃ for 15 minutes and take For the supernatant, add 1.5 times the volume of absolute ethanol and mix well; add the above mixture to the column, centrifuge at 8000 rpm for 18 seconds, discard the collected solution; add 700 μL RWT solution, centrifuge at 8000 rpm for 18 seconds, di...

Embodiment 3

[0066] Example 3 Establishment of specific serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 compositions for active pulmonary tuberculosis

[0067]Using MedCalc software to calculate the ROC curve of single serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 in the diagnosis of active pulmonary tuberculosis, including sensitivity, specificity and area under the curve (AUC) , the results showed that the AUCs of serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 were 0.723, 0.711, 0.702, 0.706, and the sensitivities were 51.2%, 67.5%, 94.9% respectively %, 90.1%, and the specificities were 87.4%, 70.5, 36.4%, and 44.2%, respectively. The results showed that the sensitivity and specificity of a single serum miRNA in the diagnosis of active pulmonary tuberculosis were not high.

[0068] Using the Logistic stepwise regression model to calculate the ROC curve of serum hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101 composition in the diagnosis of a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention provides a diagnostic kit for detecting active pulmonary tuberculosis, which is composed of RNA extraction buffer, active pulmonary tuberculosis specific serum miRNA composition, internal reference reverse transcription primers, PCR primers and fluorescent quantitative RT-PCR reaction solution, The active tuberculosis specific serum miRNA composition consisted of four differentially expressed serum miRNAs: hsa-miR-29c, hsa-miR-22, hsa-miR-320b and hsa-miR-101. The invention adopts the specific serum miRNAs combination of active pulmonary tuberculosis to detect active pulmonary tuberculosis at the level of serum miRNAs, with a sensitivity of 90.2% and a specificity of 75.0%, which has early diagnostic value for active pulmonary tuberculosis and can realize the detection of active pulmonary tuberculosis. Early warning and early diagnosis of tuberculosis.

Description

technical field [0001] The invention belongs to the research of serum biological markers, and relates to a kit for detecting miRNA specific to active pulmonary tuberculosis. A specific miRNA capable of identifying active pulmonary tuberculosis is used to capture serum biological markers and analyzed by miRNA with quantitative control , to detect active pulmonary tuberculosis in serum. Background technique [0002] Tuberculosis is a chronic pulmonary infectious disease caused by Mycobacterium tuberculosis, which is a serious threat to human health. The epidemic situation in China is very severe; there are about 1.3 million active tuberculosis patients, 1.45 million new cases per year, accounting for 18% of the global population, and 130,000 deaths per year, exceeding The sum of deaths from other infectious diseases. The high morbidity and mortality of tuberculosis, as well as airborne transmission, imposes a considerable burden on the patient, his contacts, and society. Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68C12R1/32
Inventor 李继承张星
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com